Login / Signup

Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents.

Shunya IkedaMie AzumaKenichi FujimotoHidetoshi ShibaharaSachie InoueMargaret MolineMika IshiiKazuo Mishima
Published in: Psychological medicine (2022)
In a Japanese clinical practice setting, lemborexant may represent a better investment for treating insomnia in the healthcare system in Japan.
Keyphrases
  • clinical practice
  • sleep quality
  • computed tomography
  • image quality
  • depressive symptoms
  • community dwelling